Advertisement
Screener

Pulse Biosciences, Inc. (PLSE) Price / Book

2.8 / 5 stars · 68/120 Roast Me

PULSE BIOSCIENCES, INC. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • PULSE BIOSCIENCES, INC. price/book ratio for the quarter ending 2026-06-30 was 19.69, a 102.37% increase year-over-year.
  • PULSE BIOSCIENCES, INC. price/book ratio for the quarter ending 2026-03-31 was 22.18, a 142.73% increase year-over-year.
  • PULSE BIOSCIENCES, INC. price/book ratio for the quarter ending 2025-12-31 was 11.56, a 15.70% increase year-over-year.
  • PULSE BIOSCIENCES, INC. price/book ratio for the quarter ending 2025-09-30 was 12.93, a 5.19% decline year-over-year.
  • PULSE BIOSCIENCES, INC. price/book ratio for fiscal 2026 was 19.69.
  • PULSE BIOSCIENCES, INC. price/book ratio for fiscal 2025 was 11.56, a 15.70% increase from fiscal 2024.
  • PULSE BIOSCIENCES, INC. price/book ratio for fiscal 2024 was 9.99, a 34.33% decline from fiscal 2023.
  • PULSE BIOSCIENCES, INC. price/book ratio for fiscal 2023 was 15.22, a change of 61.1 from fiscal 2022.
Available history
2016-06-30 to 2026-06-30
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-3019.69$1.96B$99.5M
2026-03-3122.18$1.47B$66.3M
2025-12-3111.56$932.46M$80.66M
2025-09-3012.93$1.2B$92.69M
2025-06-309.73$1.02B$104.49M
2025-03-319.14$1.08B$118.45M
2024-12-319.99$1.15B$114.86M
2024-09-3013.64$1.08B$79.13M
2024-06-3022.92$618M$26.97M
2024-03-3113.26$481.01M$36.29M
2023-12-3115.22$674.96M$44.36M
2023-09-304.25$221.61M$52.15M
2023-06-306.51$393.8M$60.5M
2023-03-31-11.84$126.31M-$10.67M
2022-12-31-45.88$103.14M-$2.25M
2022-09-3013.83$85.62M$6.19M
2022-06-302.43$56.8M$23.42M
2022-03-316.96$144.84M$20.8M
2021-12-3118.41$816.68M$44.36M
2021-09-3013.51$640.03M$47.39M
2021-06-308.13$485.54M$59.75M
2021-03-3130.65$625.18M$20.4M
2020-12-3126.63$609.62M$22.89M
2020-09-309.12$298.17M$32.7M
2020-06-306.21$263.06M$42.33M
2020-03-316.86$149.42M$21.77M
2019-12-319.09$279.26M$30.74M
2019-09-307.83$320.97M$40.98M
2019-06-305.5$274.14M$49.86M
2019-03-316.16$364.29M$59.11M
2018-12-313.56$236M$66.33M
2018-09-308.58$241M$28.07M
2018-06-307.29$255.65M$35.05M
2018-03-315.55$228.25M$41.1M
2017-12-318.63$396.93M$46M
2017-09-306.09$304.11M$49.94M
2017-06-3020.49$494.95M$24.16M
2017-03-3110.59$289.31M$27.33M
2016-12-313.42$86.55M$25.3M
2016-09-303.01$83.75M$27.86M
2016-06-301.96$59.78M$30.47M

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-3019.69$1.96B$99.5M
2025-12-3111.56$932.46M$80.66M
2024-12-319.99$1.15B$114.86M
2023-12-3115.22$674.96M$44.36M
2022-12-31-45.88$103.14M-$2.25M
2021-12-3118.41$816.68M$44.36M
2020-12-3126.63$609.62M$22.89M
2019-12-319.09$279.26M$30.74M
2018-12-313.56$236M$66.33M
2017-12-318.63$396.93M$46M
2016-12-313.42$86.55M$25.3M

Similar stocks

Stock NameCountryMarket CapPE Ratio
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
Heartflow, Inc. (HTFL)United States$4.225B
AtriCure, Inc. (ATRC)United States$3.089B
HAEMONETICS CORP (HAE)United States$4.821B36.52
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87